英美烟草半年盈利胜预期 正等待批准测试新冠疫苗
英美烟草(British American Tobacco)上半年经营溢利增长3.3%至53.7亿英镑,经调整每股盈利157.58便士,优於市场预期,因於高价商品销售增长以及成本削减计划抵消销量下跌。
期内收入增长1.1%至122.7亿英镑,高於市场预期的121.6亿英镑。销量则下降6.3%,主要受累於各国出入境管制令旅游需求大跌。
英美烟草重申,预计按固定汇率计算全年收入增长介乎1%至3%之间,每股盈利增长为中单位数。同时由於消费者需求持续反弹及贸易库存水平增加,预计美国行业销量将下降2.5%,而不是先前估计的4%。
另外,英美烟草表示,旗下美国生物科技公司Kentucky BioProcessing(KBP)已正等待美国食品及药品管理局批准开始对新冠病毒疫苗进行测试。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.